Cephapirin for Ox: Mastitis Uses, Dosing & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Cephapirin is a first-generation cephalosporin antibiotic used in cattle medicine, most often as an intramammary infusion for mastitis. In the U.S., the labeled products are cephapirin sodium for lactating cows and cephapirin benzathine for dry cows. These are prescription products and should be used only under your vet’s direction.

For farm-animal pages, you may see “ox” used as a species label, but the practical use information comes from approved cattle labeling. That matters because food-animal antibiotics have strict rules around route, dose, timing, and withdrawal periods. With cephalosporins in major food-producing species, extra-label use is tightly restricted, so your vet will usually match treatment to the exact approved product and label directions.

Cephapirin works by interfering with bacterial cell wall formation. It is mainly used against susceptible gram-positive mastitis pathogens, especially certain Streptococcus agalactiae and Staphylococcus aureus infections named on product labeling. It is not a catch-all mastitis drug, and culture results, herd history, stage of lactation, and milk-withdrawal planning all affect whether it is a good fit.

In practice, cephapirin is used for bovine mastitis management, but the exact use depends on the formulation. Cephapirin sodium intramammary infusion is labeled for mastitis in lactating cows and is intended to be used at the first signs of udder inflammation, milk changes, or after testing suggests infection. The label specifically lists susceptible Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant staph strains.

Cephapirin benzathine intramammary infusion is the dry-cow version. It is used at dry-off, not during active lactation, to treat existing intramammary infections during the non-lactating period. This longer-acting form is meant to stay in the udder during the dry period and has very different timing and withdrawal rules than the lactating-cow product.

Your vet may recommend cephapirin as part of a broader mastitis plan that also includes milk culture, California Mastitis Test screening, milking-hygiene review, teat-end sanitation, and decisions about whether a quarter should be treated, monitored, or cultured first. Antibiotics help selected infections, but herd management and reinfection control are also central to success.

Cephapirin dosing in cattle must follow the specific labeled product. For ToDAY (cephapirin sodium) in lactating cows, the label directs one full 10 mL syringe containing 200 mg cephapirin into each infected quarter, given immediately after the quarter has been completely milked out, then repeated once in 12 hours. The label says to reassess if there is not definite improvement within 48 hours.

For ToMORROW (cephapirin benzathine) in dry cows, the label directs one 10 mL syringe containing 300 mg cephapirin into each quarter once at dry-off. It is for dry cows only and should be used no later than 30 days before calving. Merck Veterinary Manual also notes that dry-cow intramammary therapy is generally one tube per quarter immediately after the last milking of lactation and should not be repeatedly infused into the udder.

Administration technique matters. The udder and teats should be cleaned, the teat end disinfected with alcohol, and the syringe tip inserted carefully to reduce introducing new bacteria. Because cephalosporin extra-label use is restricted in major food-producing species, pet parents and producers should not change the route, frequency, duration, or target animal without direct veterinary guidance.

Withdrawal times are a major safety point for food animals. For ToDAY, milk from treated animals must be discarded during treatment and for 96 hours after the last treatment, and treated animals must not be slaughtered for food until 4 days after the last treatment. For ToMORROW, milk must not be used for food during the first 72 hours after calving, the product must not be used within 30 days of calving, and slaughter withdrawal is 42 days after the latest infusion.

Cephapirin is usually well tolerated when used exactly as labeled, but side effects can still happen. The most important concern on product labeling is allergic or hypersensitivity reactions, especially in animals with a history of reactions to penicillin or related beta-lactam antibiotics. These reactions are described as rare, but they can be serious.

Locally, some animals may show temporary udder or teat irritation, and treatment failure can occur if the infection is caused by a non-susceptible organism, if the quarter is chronically damaged, or if bacteria are introduced during infusion. If milk changes, swelling, fever, appetite loss, or systemic illness continue or worsen after treatment starts, your vet may want culture, supportive care, or a different plan.

For food-producing animals, another major safety issue is drug residues. Using more than the labeled dose, treating too close to calving with the dry-cow product, or failing to observe milk and meat withdrawal times can create residue violations. If there is any uncertainty about timing, milk use, or slaughter eligibility, contact your vet before the animal or milk enters the food chain.

There are no widely emphasized day-to-day drug interactions listed on the product labels in the way pet parents may see with small-animal medications. Still, cephapirin should be viewed in the context of the whole mastitis plan, including other intramammary products, systemic antibiotics, anti-inflammatory drugs, and any teat sealants used around dry-off.

The biggest practical interaction issue is mixing protocols without a veterinary plan. Using another intramammary product in the same quarter, changing the labeled schedule, or combining treatments in a way that alters residue timing can create safety and compliance problems. Merck also cautions against using drugs from multiple-dose systemic vials for intramammary treatment because commercial intramammary products have better sterility control and more reliable withholding guidance.

If your ox or cow is receiving other medications, especially other beta-lactam antibiotics or dry-cow products, ask your vet to confirm compatibility, sequence, and updated withdrawal instructions. In food animals, the interaction question is often less about side effects between drugs and more about residue risk, legal use, and whether the chosen combination still fits approved labeling.